EdgeScore

IMNN · Nasdaq

Imunon, Inc.: financial statements

Financially weak · see the checkFigures in USD, fiscal years

Revenue and net income

Revenue 2017: $500KNet income 2017: -$20.4M2017Revenue 2018: $500KNet income 2018: -$11.9M2018Revenue 2019: $500KNet income 2019: -$16.9M2019Revenue 2020: $500KNet income 2020: -$21.5M2020Revenue 2021: $500KNet income 2021: -$20.8M2021Revenue 2022: $500KNet income 2022: -$35.9M2022
RevenueNet income

Operating and free cash flow

Operating cash flow 2017: -$16.6MFree cash flow 2017: -$16.7M2017Operating cash flow 2018: -$7.0MFree cash flow 2018: -$7.2M2018Operating cash flow 2019: -$20.3MFree cash flow 2019: -$20.6M2019Operating cash flow 2020: -$15.6MFree cash flow 2020: -$15.6M2020Operating cash flow 2021: -$16.2MFree cash flow 2021: -$16.5M2021Operating cash flow 2022: -$23.1MFree cash flow 2022: -$23.4M2022
Operating cash flowFree cash flow

Margins

Operating 2017: -3693.7%Operating 2018: -4213.0%Operating 2019: -4113.1%Operating 2020: -3697.3%Operating 2021: -4201.4%Operating 2022: -4984.3%Net 2017: -4080.4%Net 2018: -2376.7%Net 2019: -3370.3%Net 2020: -4296.7%Net 2021: -4153.9%Net 2022: -7179.6%201720182019202020212022
GrossOperatingNet

Returns

ROE 2017: -76.4%ROE 2018: -57.0%ROE 2019: -115.7%ROE 2020: -115.4%ROE 2021: -37.2%ROE 2022: -122.4%ROIC 2017: -95.6%ROIC 2018: -69.7%ROIC 2019: -107.9%ROIC 2020: -142.0%ROIC 2021: -92.2%ROIC 2022: -79.6%ROA 2017: -42.9%ROA 2018: -25.4%ROA 2019: -44.0%ROA 2020: -57.2%ROA 2021: -28.0%ROA 2022: -81.6%201720182019202020212022
ROEROICROA

Income statement

USD201720182019202020212022Last year
Revenue$500K$500K$500K$500K$500K$500K+0%
Operating income-$18.5M-$21.1M-$20.6M-$18.5M-$21.0M-$24.9M-19%
EBITDA-$17.9M-$20.7M-$19.8M-$17.7M-$20.3M-$24.2M-19%
Interest expense$91.8K$712K$1.4M$1.3M$570K$5.0M+782%
Profit before tax-$20.4M-$22.3M-$18.7M-$23.3M-$22.2M-$37.5M-69%
Income tax—-$10.4M-$1.8M-$1.8M-$1.4M-$1.6M-13%
Net income-$20.4M-$11.9M-$16.9M-$21.5M-$20.8M-$35.9M-73%

Cash flow

USD201720182019202020212022Last year
Operating cash flow-$16.6M-$7.0M-$20.3M-$15.6M-$16.2M-$23.1M-42%
Capital expenditure$38.6K$138K$349K$19.1K$312K$268K-14%
Free cash flow-$16.7M-$7.2M-$20.6M-$15.6M-$16.5M-$23.4M-41%
Depreciation & amortization$553K$357K$722K$742K$703K$732K+4%

Balance sheet

USD201720182019202020212022Last year
Cash$11.4M$13.4M$6.9M$17.2M$19.6M$11.5M-41%
Current assets$24.3M$28.1M$16.2M$18.8M$51.9M$36.8M-29%
Total assets$47.5M$46.9M$38.3M$37.5M$74.0M$44.0M-41%
Current liabilities$6.2M$6.1M$7.9M$6.8M$6.8M$10.0M+48%
Financial debt—$9.4M$9.8M$5.1M—$6.0M
Total liabilities$20.8M$26.0M$23.7M$18.9M$18.3M$14.6M-20%
Shareholders' equity$26.7M$20.9M$14.6M$18.6M$55.8M$29.3M-47%
Net debt-$11.4M-$3.9M$2.9M-$12.1M-$19.6M-$5.5M+72%

Ratios

201720182019202020212022Last year
Operating margin-3693.7%-4213.0%-4113.1%-3697.3%-4201.4%-4984.3%
Net margin-4080.4%-2376.7%-3370.3%-4296.7%-4153.9%-7179.6%
Return on equity-76.4%-57.0%-115.7%-115.4%-37.2%-122.4%
Return on assets-42.9%-25.4%-44.0%-57.2%-28.0%-81.6%
Return on invested capital-95.6%-69.7%-107.9%-142.0%-92.2%-79.6%
Debt / equity—0.450.670.27—0.20
Interest coverage-201.3x-29.6x-14.8x-14.3x-36.9x-5.0x
Current ratio3.924.612.062.797.673.66
Quick ratio3.924.612.062.797.673.66

Data source: SEC EDGAR, company annual reports. Lines a company does not report are left empty. Free cash flow is operating cash flow minus capital expenditure. Ratios use the same formulas as the EdgeScore check.

For information and education only. Not investment advice. Data may contain errors.